Principles and Applications of Clinical Mass Spectrometry
Small Molecules, Peptides, and Pathogens
- 1st Edition - June 18, 2018
- Latest edition
- Editors: Nader Rifai, A. Rita Horvath, Carl T. Wittwer, Andy Hoofnagle
- Language: English
Principles and Applications of Clinical Mass Spectrometry: Small Molecules, Peptides, and Pathogens is a concise resource for quick implementation of mass spectrometry methods i… Read more
Principles and Applications of Clinical Mass Spectrometry: Small Molecules, Peptides, and Pathogens is a concise resource for quick implementation of mass spectrometry methods in clinical laboratory work. Focusing on the practical use of these techniques, the first half of the book covers principles of chromatographic separations, principles and types of mass spectrometers, and sample preparation for analysis; the second half outlines the main applications of this technology within clinical laboratory settings, including determination of small molecules and peptides, as well as pathogen identification. A thorough yet succinct guide to using mass spectrometry technology in the clinical laboratory, Principles and Applications of Clinical Mass Spectrometry: Small Molecules, Peptides, and Pathogens is an essential resource for chemists, pharmaceutical and biotech researchers, certain government agencies, and standardization groups.
- Provides concrete examples of the main applications of mass spectrometry technology
- Describes current capabilities of the LC- and MS-based analytical methods
- Details methods for successful analytical work in the field
Chemists working in clinical laboratories (hospitals and commercial labs), pharmaceutical researchers, biotech researchers, government agencies (CDC, NIST, EPA) and standardization groups, forensic scientists and criminologists, biodefense and bioterrorism researchers, mass spec manufacturers
1. Chromatography
Hage
2. Mass spectrometry
Rockwood, Kushnir, Clarke
3. Sample preparation for mass spectrometry applications
Wells
4. Mass spectrometry applications in infectious disease and pathogens identification
Heaton, Patel
5. Development and Validation of Small Molecule Analytes By Liquid Chromatography-Tandem Mass Spectrometry
Grant, Rappold
6. Proteomics
Hoofnagle, Bystrom
- Edition: 1
- Latest edition
- Published: June 18, 2018
- Language: English
NR
Nader Rifai
Affiliations and expertise
Professor Department of Pathology Harvard Medical School; The Louis Joseph Gay-Lussac Chair in Laboratory Medicine Boston Children's Hospital; Director of Clinical Chemistry Laboratory Medicine Boston Children's Hospital Boston, Massachusetts, USAAH
A. Rita Horvath
Andrea Rita Horvath’s key research interests include evidence-based laboratory medicine (EBLM) including evidence-based monitoring, guideline development, and evaluation of new biomarkers and overdiagnosis. She holds advisory roles on test utilization and reimbursement policy at the National Prescribing Service of Australia and Medicare. She has published 160 research papers and 16 book chapters and has been an invited speaker at over 100 international conferences. Her national and international leadership positions include Chair of the IFCC Committee on EBLM (2003-2008); European Communities Confederation of Clinical Chemistry and Laboratory Medicine (EC4) Secretary (2005-2007); President of the Hungarian Society (2005-2008) and the Hungarian College of Laboratory Medicine (2008-2009); President-Elect (2007-2009), President (2009-2011) and Past President (2012-2013) of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM); chair of the EFLM working group on Test Evaluation (2011-2015) and member of the Board of Directors of the American Association of Clinical Chemistry (2014-2016).
Affiliations and expertise
Professor, School of Medical Sciences, University of New South Wales, Sydney, AustraliaCW
Carl T. Wittwer
Affiliations and expertise
Professor Emeritus,Pathology,University of Utah ,Salt Lake City, UtahAH
Andy Hoofnagle
Andy Hoofnagle received his undergraduate education at Cornell University. He obtained his medical degree from the University of Colorado Health Sciences and his PhD from the University of Colorado, Boulder as part of the Medical Scientist Training Program. During his residency and chief residency in Clinical Pathology in the Department of Laboratory Medicine at the University of Washington, he did his post-doctoral work in the laboratory of Jay Heinecke, Department of Medicine. He was then promoted to Assistant Professor of Laboratory Medicine and now serves as the Director of Clinical Mass Spectrometry.
Dr. Hoofnagle’s laboratory focuses on using proteomic and metabolomic approaches to investigate the intersection of inflammation and lipid metabolism. His laboratory is pioneering the use of immunoaffinity peptide enrichment strategies of analyte-specific peptides from tryptic digests in the clinical analysis of low-abundance serum proteins. The laboratory has developed assays for small molecule analytes, including arginine, arginine metabolites, and vitamin D, which are being used in basic science and large-scale clinical studies. Several mouse models are being used to assess the importance of complement regulatory proteins in insulin sensitivity and lipid metabolism. All of these studies are in collaboration with outstanding investigators from the University of Washington and elsewhere.
Affiliations and expertise
Professor, Department of Laboratory Medicine
Head, Division of Clinical Chemistry, University of Washington
Seattle, WA USARead Principles and Applications of Clinical Mass Spectrometry on ScienceDirect